Physician

Alice Abraham, M.D.

According to 2025 Medicare claims, Alice Abraham, M.D. (NPI: 1083857213) practices endocrinology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Bergen, NJ. This provider's primary affiliated billing organization is MEDICAL ASSOCIATES OF ENGLEWOOD, PC (NPI: 1952681918; TIN: 452548322) and primary practice location at 07631-1808. Abraham is affiliated with the Englewood Health ACO, LLC (ACO ID: A5653), participating under the MSSP model.

Abraham's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 387 traditional Medicare patients, billed 1,780 HCPCS/CPT codes, and received $86,188 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,220 prescription claims across 412 beneficiaries totaling $1,268,168 in drug costs, led by Ozempic (Semaglutide). DME data shows 294 claims. Open Payments data shows 55 records totaling $837. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $8,031 to $86,188. Similarly, Part D prescription costs have moved sharply higher in recent years, from $33,311 to $1,268,168. For DME billing, reported payments moved sharply higher in recent years, from $5,445 to $56,173.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	47	106	$8,031
2016	169	1,053	$46,164
2017	177	1,347	$48,092
2018	275	2,430	$85,997
2019	284	1,780	$70,139
2020	264	888	$50,456
2021	278	966	$63,062
2022	322	1,077	$66,721
2023	347	1,192	$70,268
2024	387	1,780	$86,188

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	50	226	$33,311
2016	109	700	$198,486
2017	177	1,286	$319,482
2018	232	1,837	$464,955
2019	270	2,031	$573,584
2020	283	2,170	$642,503
2021	331	2,351	$825,928
2022	353	2,598	$920,708
2023	388	2,915	$1,237,685
2024	412	3,220	$1,268,168

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	40	90	$4,655
2017	71	155	$2,653
2018	92	336	$20,564
2019	143	443	$31,620
2020	133	436	$28,323
2021	121	460	$39,943
2022	114	460	$49,863
2023	94	410	$52,641
2024	92	294	$52,201

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	277	510	$99
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	169	270	$74
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	248	425	$14
83036	Hemoglobin a1c level	69	119	$9
36415	Insertion of needle into vein for collection of blood sample	203	322	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	251	10,438	$336,726
Jardiance	Empagliflozin	195	10,950	$210,465
Mounjaro	Tirzepatide	97	4,552	$163,694
Trulicity	Dulaglutide	88	3,818	$131,270
Farxiga	Dapagliflozin Propanediol	28	2,280	$42,443

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	21	105	$45,050
E0784	External ambulatory infusion pump, insulin	Y	N/R	15	$5,271
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	46	116	$1,780
A4259	Lancets, per box of 100	N	25	47	$68
A4256	Normal, low and high calibrator solution / chips	N	N/R	11	$32

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	55	$837	Lilly USA, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alice Abraham, M.D.?

Tedicare shows public-source Medicare data for Alice Abraham, M.D. (NPI 1083857213), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alice Abraham, M.D. have ACO affiliation data?

Alice Abraham, M.D. is shown with ACO affiliation data for Englewood Health ACO, LLC (MSSP, ACO ID A5653).

What billing organization is linked to Alice Abraham, M.D.?

Alice Abraham, M.D. is linked to MEDICAL ASSOCIATES OF ENGLEWOOD, PC (billing NPI 1952681918) in the available physician profile data.

Does Alice Abraham, M.D. have Open Payments data?

Alice Abraham, M.D. has 55 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.